US 7531656
Synthesis of gatifloxacin
granted A61PA61P31/04
Quick answer
US patent 7531656 (Synthesis of gatifloxacin) held by Teva Pharmaceuticals USA, Inc. expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceuticals USA, Inc.
- Grant date
- Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P31/04